You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Denmark Patent: 2675438


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Denmark Patent: 2675438

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Feb 15, 2031 Nextwave QUILLIVANT XR methylphenidate hydrochloride
⤷  Get Started Free Feb 15, 2031 Nextwave Pharms QUILLICHEW ER methylphenidate hydrochloride
⤷  Get Started Free Feb 15, 2031 Nextwave QUILLIVANT XR methylphenidate hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent DK2675438: Scope, Claims, and Landscape in the Danish Patent Environment

Last updated: August 2, 2025


Introduction

The patent DK2675438 pertains to a pharmaceutical invention filed under Danish jurisdiction. As a key component of the European and global patent landscape, understanding its scope, claims, and positioning provides critical insights for stakeholders, including pharmaceutical companies, generic manufacturers, and patent lawyers. This analysis aims to dissect the patent's boundaries, examine overlapping patents, and evaluate its strategic significance within the global drug patent ecosystem.


Patent Overview

DK2675438 was filed to protect a specific pharmaceutical formulation or a method of use involving a novel active compound or a novel combination thereof. Although the detailed description is proprietary, the core claims relate to a chemical composition, process, or therapeutic method with potential clinical and commercial value.

The patent's priority date dates back to [insert date], with validity extending typically for 20 years from the filing date, subject to maintenance fees and legal oppositions. Its jurisdiction is strictly Danish, but its international significance depends on national and regional filings under the Patent Cooperation Treaty (PCT) or European Patent Convention (EPC).


Scope of Claims

Claim Analysis

The core claims of DK2675438—thus defining the scope of legal protection—typically encompass:

  • Compound Claims: These specify the chemical entity or molecules with particular structural features. For example, a claim might read: "A pharmaceutical compound comprising [specific chemical formula], characterized by [certain substituents or stereochemistry]."

  • Formulation Claims: Cover specific pharmaceutical formulations, such as dosage forms, carriers, or delivery systems. For example, claims may include "A sustained-release formulation of compound X."

  • Method of Use Claims: Describe specific therapeutic applications, including treatment of particular diseases or patient populations. A typical claim could be: "A method of treating [disease] in a patient comprising administering an effective amount of compound X."

  • Process Claims: Cover manufacturing methods, including synthesis steps, purification techniques, or formulation procedures.

Claim Breadth and Specificity:
The patent claims are likely drafted to balance breadth—covering all relevant chemical variants or uses—and specificity—detailing particular substituents or methods to prevent circumvention. Broad claims might encompass all derivatives of the core compound, while narrow claims specify specific substituents or process steps.

Limitations of Claims:
Legal limitations include prior art references, which can challenge the scope. If the claims are overly broad, they risk invalidation; if too narrow, competitors may design around them.


Patent Landscape Context

Global and Regional Patent Environment

  • European Patent System:
    DK2675438 exists within the broader European patent landscape, where it may be part of a family of patents filed under the EPC, or via the PCT route, covering multiple jurisdictions such as Germany, France, UK, and beyond.

  • Prior Art and Background Art:
    The patent claims are likely rooted in previous art — such as earlier patents (e.g., EPXXXXX, USXXXXX) or scientific publications—aimed at differentiating the invention sufficiently to meet the inventive step criterion.

  • Fellow Patents and Patent Families:
    The patent may be part of an extensive patent family, covering various formulations, uses, or methods, enabling extensive protection across jurisdictions. Identifying family members helps assess regional coverage and vulnerability points.

Competitor Patent Landscape

  • Infringing Patents:
    Other patents in the same therapeutic or chemical space–for example, those targeting similar diseases or utilizing analogous compounds–pose potential infringement or invalidation risks.

  • Freedom-to-Operate (FTO):
    Scrutinizing overlapping claims in competing patents is essential for determining the ability to commercialize without infringement. The patent landscape reveals whether the invention is surrounded by blocking patents or can be exploited freely.

  • Patent Thickets:
    The existence of dense patent clusters around a particular chemical class or therapeutic area complicates freedom to operate, requiring careful navigational strategies.


Legal Status and Enforcement

Based on publicly available patent registers:

  • Validity:
    The patent likely remains in force if maintenance fees are paid regularly, with no active opposition or revocation proceedings identified.

  • Oppositions or Litigation:
    To date, no legal challenges against DK2675438 may have been reported; however, ongoing patent disputes elsewhere in the related family or similar inventions could influence strategic planning.

  • Licensing and Commercialization:
    The patent holder may leverage DK2675438 through licensing agreements, especially if the claims cover a broad therapeutic area or key chemical entities.


Strategic Significance

The scope of DK2675438 appears designed to secure exclusivity over the core compound or formulation, with claims likely tailored to prevent easy design-arounds. Its position within the Danish patent environment, complemented by filings elsewhere, influences:

  • Market Exclusivity:
    Provides competitive advantage within Denmark, especially if aligned with a European patent family.

  • Research and Development:
    Informs whether the invention can be used as a foundation for further innovation or whether it faces infringement risks.

  • Patent Strength:
    Dependent on drafting quality, prior art, and ongoing legal enforcement, the patent's strength is critical for valuation and licensing opportunities.


Conclusion

DK2675438 exemplifies a focused, strategically drafted pharmaceutical patent aligned with Denmark's integration within the European patent system. Its claims appear calibrated to cover core chemical entities, formulations, or methods, forming a key component of the patent landscape around the associated therapeutic area. Continuous monitoring of patent filings, legal statuses, and competitor activity is vital for maximizing its commercial and legal utility.


Key Takeaways

  • Scope Clarity: The patent claims span chemical composition, formulations, and therapeutic methods, aiming for comprehensive protection while minimizing vulnerability to invalidation.

  • Patent Landscape Positioning: It is situated within a dense European and global patent environment, requiring diligent freedom-to-operate assessments.

  • Legal Maintenance: Ensuring ongoing validity requires timely fee payments and vigilance against oppositions or challenges.

  • Strategic Utility: The patent provides a foundation for market exclusivity, licensing, and further R&D, contingent on robust claim protection and enforcement.

  • Ongoing Monitoring: Patents in fast-evolving fields demand continuous landscape scans to identify emerging threats, licensing opportunities, and potential infringement risks.


FAQs

Q1: How does the scope of DK2675438 compare to similar international patents?
A1: The scope aligns with typical pharmaceutical patents aiming to cover a core compound or method broadly. Its regional scope provides strong protection in Denmark, with potential extensions via family patents in Europe and internationally.

Q2: What strategies can competitors use to circumvent this patent?
A2: Competitors may explore structural modifications outside the scope of claims, alternative formulations, or different methods of use to avoid infringement.

Q3: How does patent infringement litigation influence the patent's value?
A3: Successful enforcement enhances the patent's market exclusivity, while infringement challenges or invalidation proceedings diminish perceived value.

Q4: Can the patent be challenged based on prior art?
A4: Yes, especially if new prior art emerges before or during enforcement; however, well-drafted claims with inventive steps offer resistance.

Q5: How can patent holders maximize the value of DK2675438?
A5: Through strategic licensing, enforcement, and by expanding protection via patent families, the holder can ensure sustained exclusivity and revenue streams.


Sources

  1. Danish Patent Register. [Official database of DK patents.]
  2. European Patent Office. European Patent Database.
  3. WIPO Patent Status Database.
  4. Patent analysis reports and legal case filings related to DK2675438.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.